ImportRefusal LogoImportRefusal

Aventis Pharma, S.A. De C.V.

⚠️ High Risk

FEI: 3003450798 • Queretaro, QRO. • MEXICO

FEI

FEI Number

3003450798

📍

Location

Queretaro, QRO.

🇲🇽

Country

MEXICO
🏢

Address

Calle 2a # 42 Zona Industrial Benito, , Queretaro, QRO., Mexico

High Risk

FDA Import Risk Assessment

54.6
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

13
Total Refusals
3
Unique Violations
3/24/2003
Latest Refusal
11/27/2001
Earliest Refusal

Score Breakdown

Violation Severity
80.0×40%
Refusal Volume
42.5×30%
Recency
0.0×20%
Frequency
98.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7513×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
3/24/2003
62FBJ20IODINE (ANTI-INFECTIVE, TOPICAL)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
64ADQ20TRICLOSAN (DISINFECTANT)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
64ADJ20TRICLOSAN (DISINFECTANT)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
64ABR20TRICLOSAN (DISINFECTANT)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
64ABR20TRICLOSAN (DISINFECTANT)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
64ABR20TRICLOSAN (DISINFECTANT)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/24/2003
60LBJ99ANALGESIC, N.E.C.
75UNAPPROVED
Southwest Import District Office (SWI-DO)
4/22/2002
61WBR39UNDECYLENIC ACID (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
4/22/2002
61WBJ39UNDECYLENIC ACID (ANTI-FUNGAL) (NOT ANTIBIOTIC)
75UNAPPROVED
Southwest Import District Office (SWI-DO)
3/7/2002
53LH04FOOT POWDERS AND SPRAYS (SKIN CARE PREPARATIONS)
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
11/27/2001
56GBJ99ANTIFUNGAL N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
11/27/2001
56GBJ99ANTIFUNGAL N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
11/27/2001
56GBJ99ANTIFUNGAL N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Aventis Pharma, S.A. De C.V.'s FDA import refusal history?

Aventis Pharma, S.A. De C.V. (FEI: 3003450798) has 13 FDA import refusal record(s) in our database, spanning from 11/27/2001 to 3/24/2003.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Aventis Pharma, S.A. De C.V.'s FEI number is 3003450798.

What types of violations has Aventis Pharma, S.A. De C.V. received?

Aventis Pharma, S.A. De C.V. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Aventis Pharma, S.A. De C.V. come from?

All FDA import refusal data for Aventis Pharma, S.A. De C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.